

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * actin filament-based movement (GO:0030048) | 8.79615242 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.15658618 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.96951345 |
| 4 | sarcomere organization (GO:0045214) | 7.51319508 |
| 5 | myotube cell development (GO:0014904) | 7.04590038 |
| 6 | * striated muscle contraction (GO:0006941) | 6.84158575 |
| 7 | myofibril assembly (GO:0030239) | 6.75624219 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.43919611 |
| 9 | skeletal muscle adaptation (GO:0043501) | 6.26189703 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.99583608 |
| 11 | * muscle contraction (GO:0006936) | 5.98338268 |
| 12 | skeletal muscle tissue regeneration (GO:0043403) | 5.84951373 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.73328098 |
| 14 | cardiac myofibril assembly (GO:0055003) | 5.53664795 |
| 15 | response to inactivity (GO:0014854) | 5.53523278 |
| 16 | cytidine deamination (GO:0009972) | 5.46207373 |
| 17 | cytidine metabolic process (GO:0046087) | 5.46207373 |
| 18 | cytidine catabolic process (GO:0006216) | 5.46207373 |
| 19 | muscle fiber development (GO:0048747) | 5.42166130 |
| 20 | actomyosin structure organization (GO:0031032) | 5.40483000 |
| 21 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.37272935 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.31841149 |
| 23 | * muscle system process (GO:0003012) | 5.29529458 |
| 24 | NADH metabolic process (GO:0006734) | 5.28516453 |
| 25 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.12303580 |
| 26 | muscle cell fate commitment (GO:0042693) | 4.99321854 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.98397346 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 4.95143766 |
| 29 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.91309323 |
| 30 | cardiac muscle contraction (GO:0060048) | 4.85693050 |
| 31 | cellular polysaccharide catabolic process (GO:0044247) | 4.84450119 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.71231164 |
| 33 | skeletal muscle tissue development (GO:0007519) | 4.70069533 |
| 34 | muscle cell cellular homeostasis (GO:0046716) | 4.62750017 |
| 35 | striated muscle cell development (GO:0055002) | 4.61928380 |
| 36 | response to muscle activity (GO:0014850) | 4.54162860 |
| 37 | striated muscle adaptation (GO:0014888) | 4.51434089 |
| 38 | positive regulation of myotube differentiation (GO:0010831) | 4.47704016 |
| 39 | regulation of sarcomere organization (GO:0060297) | 4.47191731 |
| 40 | muscle organ development (GO:0007517) | 4.45032558 |
| 41 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.43703491 |
| 42 | muscle structure development (GO:0061061) | 4.38569573 |
| 43 | creatine metabolic process (GO:0006600) | 4.38338152 |
| 44 | polysaccharide catabolic process (GO:0000272) | 4.35430081 |
| 45 | cardiac muscle cell development (GO:0055013) | 4.34508799 |
| 46 | regulation of myoblast differentiation (GO:0045661) | 4.31869001 |
| 47 | 2-oxoglutarate metabolic process (GO:0006103) | 4.31029980 |
| 48 | negative regulation of protein localization to cell surface (GO:2000009) | 4.27824291 |
| 49 | muscle organ morphogenesis (GO:0048644) | 4.18776464 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 4.17183887 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 4.17183887 |
| 52 | tricarboxylic acid cycle (GO:0006099) | 4.16859120 |
| 53 | carnitine shuttle (GO:0006853) | 4.12190558 |
| 54 | fructose metabolic process (GO:0006000) | 4.08922956 |
| 55 | gluconeogenesis (GO:0006094) | 4.08528674 |
| 56 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.08489750 |
| 57 | striated muscle atrophy (GO:0014891) | 4.06048835 |
| 58 | cardiac cell development (GO:0055006) | 4.05510690 |
| 59 | glycogen metabolic process (GO:0005977) | 4.04647375 |
| 60 | myoblast fusion (GO:0007520) | 4.03384721 |
| 61 | muscle cell development (GO:0055001) | 3.98619433 |
| 62 | glycogen biosynthetic process (GO:0005978) | 3.96708651 |
| 63 | glucan biosynthetic process (GO:0009250) | 3.96708651 |
| 64 | cellular glucan metabolic process (GO:0006073) | 3.95958119 |
| 65 | glucan metabolic process (GO:0044042) | 3.95958119 |
| 66 | heart process (GO:0003015) | 3.94960729 |
| 67 | heart contraction (GO:0060047) | 3.94960729 |
| 68 | regulation of striated muscle contraction (GO:0006942) | 3.88957239 |
| 69 | regulation of membrane repolarization (GO:0060306) | 3.85789614 |
| 70 | myotube differentiation (GO:0014902) | 3.70053257 |
| 71 | muscle adaptation (GO:0043500) | 3.68939852 |
| 72 | striated muscle hypertrophy (GO:0014897) | 3.68016956 |
| 73 | muscle tissue morphogenesis (GO:0060415) | 3.67832606 |
| 74 | hexose biosynthetic process (GO:0019319) | 3.66595236 |
| 75 | regulation of myotube differentiation (GO:0010830) | 3.63988750 |
| 76 | skeletal muscle cell differentiation (GO:0035914) | 3.63809109 |
| 77 | cardiac muscle hypertrophy (GO:0003300) | 3.62813650 |
| 78 | adult heart development (GO:0007512) | 3.61431678 |
| 79 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.61322569 |
| 80 | positive regulation of myoblast differentiation (GO:0045663) | 3.58970848 |
| 81 | regulation of skeletal muscle fiber development (GO:0048742) | 3.58338491 |
| 82 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.49679035 |
| 83 | muscle atrophy (GO:0014889) | 3.49408467 |
| 84 | syncytium formation (GO:0006949) | 3.49248124 |
| 85 | IMP metabolic process (GO:0046040) | 3.48833974 |
| 86 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.46962538 |
| 87 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.46962538 |
| 88 | fatty acid transmembrane transport (GO:1902001) | 3.45796059 |
| 89 | regulation of the force of heart contraction (GO:0002026) | 3.44975293 |
| 90 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.41241472 |
| 91 | glycogen catabolic process (GO:0005980) | 3.41176930 |
| 92 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.41124176 |
| 93 | purine nucleotide salvage (GO:0032261) | 3.36760763 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.35691938 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.35691938 |
| 96 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.31702859 |
| 97 | muscle hypertrophy in response to stress (GO:0003299) | 3.31702859 |
| 98 | cardiac muscle adaptation (GO:0014887) | 3.31702859 |
| 99 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.28536053 |
| 100 | response to activity (GO:0014823) | 3.27554536 |
| 101 | negative regulation of potassium ion transport (GO:0043267) | 3.26989423 |
| 102 | striated muscle tissue development (GO:0014706) | 3.26667027 |
| 103 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.26531519 |
| 104 | muscle hypertrophy (GO:0014896) | 3.26479163 |
| 105 | negative regulation of muscle hypertrophy (GO:0014741) | 3.26333768 |
| 106 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.22781311 |
| 107 | AMP metabolic process (GO:0046033) | 3.22270286 |
| 108 | regulation of sulfur metabolic process (GO:0042762) | 3.22238571 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.22230363 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.20724891 |
| 111 | negative regulation of necroptotic process (GO:0060546) | 3.19997197 |
| 112 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.19329692 |
| 113 | otic vesicle formation (GO:0030916) | 3.18932598 |
| 114 | regulation of actin filament-based movement (GO:1903115) | 3.18540369 |
| 115 | glucan catabolic process (GO:0009251) | 3.16767404 |
| 116 | quinone biosynthetic process (GO:1901663) | 3.11800888 |
| 117 | ubiquinone biosynthetic process (GO:0006744) | 3.11800888 |
| 118 | * muscle filament sliding (GO:0030049) | 14.5280662 |
| 119 | * actin-myosin filament sliding (GO:0033275) | 14.5280662 |
| 120 | plasma membrane repair (GO:0001778) | 11.9257453 |
| 121 | * actin-mediated cell contraction (GO:0070252) | 11.8600446 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 10.5493176 |
| 123 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.1463917 |
| 124 | * skeletal muscle contraction (GO:0003009) | 10.1048569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.39835774 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.58365056 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.45110835 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.98987279 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.98013464 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.81901904 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.80720275 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.80720275 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.69983038 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.66199242 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.45447757 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.35809047 |
| 13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.76532413 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.51921652 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.46577432 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.32481499 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21327183 |
| 18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.18507657 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09796672 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.94168822 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.93740501 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91962874 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91498141 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88662466 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.88075809 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87852786 |
| 27 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.84050492 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.83292999 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.81361917 |
| 30 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.77971726 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.74224511 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72349081 |
| 33 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.68515601 |
| 34 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.67751057 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63264712 |
| 36 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.62866914 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.62022934 |
| 38 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.61181027 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57458970 |
| 40 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56584657 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55629422 |
| 42 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.53598409 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50857607 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50544332 |
| 45 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45391893 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44114395 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36033653 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.35305958 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31756577 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26623513 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24919946 |
| 52 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.23930607 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23610001 |
| 54 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.23408592 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22036659 |
| 56 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21618964 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21031297 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21013021 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21012490 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17707548 |
| 61 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16019180 |
| 62 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15747929 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15197236 |
| 64 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14782970 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14057303 |
| 66 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.12358200 |
| 67 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12295983 |
| 68 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.11867828 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11492207 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11486588 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09812186 |
| 72 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08600050 |
| 73 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08393119 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08389510 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08371648 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06556156 |
| 77 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05704010 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05167524 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04405895 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.03566786 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03151168 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02748619 |
| 83 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00691894 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00662543 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99354322 |
| 86 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99298665 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98938448 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98719300 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98461507 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98275582 |
| 91 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.97529069 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97279676 |
| 93 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.95867088 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95369411 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95221339 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94540002 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 0.94048881 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93222344 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92904361 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.92020750 |
| 101 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.91318416 |
| 102 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91140958 |
| 103 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91060477 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90583593 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90583593 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89949442 |
| 107 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89204950 |
| 108 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87796151 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84912632 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84828421 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84827957 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84649157 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84209025 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83566272 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83177829 |
| 116 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82863374 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82486658 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82070923 |
| 119 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82051785 |
| 120 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.81611823 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80779739 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78875558 |
| 123 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78491018 |
| 124 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77400551 |
| 125 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.76489709 |
| 126 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76230461 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76154352 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 0.75972744 |
| 129 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75964353 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.75856001 |
| 131 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.75533411 |
| 132 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74874895 |
| 133 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73972418 |
| 134 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.71985409 |
| 135 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71935902 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71578069 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.71538753 |
| 138 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.70437710 |
| 139 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.70288136 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.70088397 |
| 141 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.69461785 |
| 142 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.69243585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.56444212 |
| 2 | MP0000749_muscle_degeneration | 6.47467185 |
| 3 | MP0000751_myopathy | 6.27283087 |
| 4 | MP0003646_muscle_fatigue | 5.15826974 |
| 5 | MP0000747_muscle_weakness | 4.23198951 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 4.07814450 |
| 7 | MP0002106_abnormal_muscle_physiology | 4.06709745 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.84986538 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.78221490 |
| 10 | MP0000759_abnormal_skeletal_muscle | 3.64585842 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.61621363 |
| 12 | MP0005369_muscle_phenotype | 3.45429465 |
| 13 | MP0002269_muscular_atrophy | 3.27131266 |
| 14 | MP0004084_abnormal_cardiac_muscle | 3.23393389 |
| 15 | MP0000733_abnormal_muscle_development | 3.00638995 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.99455069 |
| 17 | MP0005330_cardiomyopathy | 2.84963950 |
| 18 | MP0004233_abnormal_muscle_weight | 2.61022844 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.52634462 |
| 20 | MP0004130_abnormal_muscle_cell | 2.24755939 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.14853876 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.05318223 |
| 23 | MP0003950_abnormal_plasma_membrane | 2.04201461 |
| 24 | MP0004484_altered_response_of | 1.96812857 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.84431912 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.80750204 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.69579781 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.61567257 |
| 29 | MP0004270_analgesia | 1.49356485 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.44101397 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.44101397 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.44044882 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33972308 |
| 34 | MP0002971_abnormal_brown_adipose | 1.32133928 |
| 35 | MP0003828_pulmonary_edema | 1.20617600 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.17449087 |
| 37 | MP0006138_congestive_heart_failure | 1.15061832 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.14681671 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.13406702 |
| 40 | MP0001661_extended_life_span | 1.06851731 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.04942578 |
| 42 | MP0002127_abnormal_cardiovascular_syste | 0.98211840 |
| 43 | MP0000003_abnormal_adipose_tissue | 0.92973551 |
| 44 | MP0002234_abnormal_pharynx_morphology | 0.91940549 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88490242 |
| 46 | MP0005266_abnormal_metabolism | 0.86773404 |
| 47 | MP0002822_catalepsy | 0.82127102 |
| 48 | MP0000266_abnormal_heart_morphology | 0.80536484 |
| 49 | MP0004085_abnormal_heartbeat | 0.78357205 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 0.77907193 |
| 51 | MP0004134_abnormal_chest_morphology | 0.76280789 |
| 52 | MP0005503_abnormal_tendon_morphology | 0.71795248 |
| 53 | MP0010030_abnormal_orbit_morphology | 0.70052721 |
| 54 | MP0004510_myositis | 0.69206811 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.68164677 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 0.67085674 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 0.65953115 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 0.65765809 |
| 59 | MP0000762_abnormal_tongue_morphology | 0.60197575 |
| 60 | MP0002114_abnormal_axial_skeleton | 0.54619175 |
| 61 | MP0003385_abnormal_body_wall | 0.53731774 |
| 62 | MP0003879_abnormal_hair_cell | 0.51292884 |
| 63 | MP0000343_altered_response_to | 0.50774262 |
| 64 | MP0005670_abnormal_white_adipose | 0.50533095 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 0.48599762 |
| 66 | MP0005083_abnormal_biliary_tract | 0.47617619 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.47538779 |
| 68 | MP0009672_abnormal_birth_weight | 0.47439967 |
| 69 | MP0005623_abnormal_meninges_morphology | 0.47253422 |
| 70 | MP0003045_fibrosis | 0.45249756 |
| 71 | MP0004197_abnormal_fetal_growth/weight/ | 0.45157761 |
| 72 | MP0002128_abnormal_blood_circulation | 0.43295621 |
| 73 | MP0008961_abnormal_basal_metabolism | 0.42310579 |
| 74 | MP0003279_aneurysm | 0.42177372 |
| 75 | MP0005451_abnormal_body_composition | 0.41037449 |
| 76 | MP0004142_abnormal_muscle_tone | 0.39558457 |
| 77 | MP0003948_abnormal_gas_homeostasis | 0.38940347 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.37687482 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.37145430 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 0.34923806 |
| 81 | MP0003941_abnormal_skin_development | 0.34604458 |
| 82 | MP0005452_abnormal_adipose_tissue | 0.34198940 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33743294 |
| 84 | MP0004147_increased_porphyrin_level | 0.32667767 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.31486101 |
| 86 | MP0002925_abnormal_cardiovascular_devel | 0.31177449 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.30933718 |
| 88 | MP0001943_abnormal_respiration | 0.30788069 |
| 89 | MP0005275_abnormal_skin_tensile | 0.29641682 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.29444764 |
| 91 | MP0004858_abnormal_nervous_system | 0.29350567 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.29098876 |
| 93 | MP0005187_abnormal_penis_morphology | 0.27731099 |
| 94 | MP0005165_increased_susceptibility_to | 0.27201361 |
| 95 | MP0002932_abnormal_joint_morphology | 0.26762373 |
| 96 | MP0000428_abnormal_craniofacial_morphol | 0.26177986 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.26107592 |
| 98 | MP0005332_abnormal_amino_acid | 0.25863021 |
| 99 | MP0008569_lethality_at_weaning | 0.25795711 |
| 100 | MP0001614_abnormal_blood_vessel | 0.24833181 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.24441232 |
| 102 | MP0005334_abnormal_fat_pad | 0.23148023 |
| 103 | MP0003959_abnormal_lean_body | 0.23105135 |
| 104 | MP0003755_abnormal_palate_morphology | 0.23055254 |
| 105 | MP0005535_abnormal_body_temperature | 0.23047213 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.22406555 |
| 107 | MP0005423_abnormal_somatic_nervous | 0.22330922 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.21763116 |
| 109 | MP0001784_abnormal_fluid_regulation | 0.21598737 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.20732119 |
| 111 | MP0008770_decreased_survivor_rate | 0.19645172 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.18485039 |
| 113 | MP0003011_delayed_dark_adaptation | 0.18471670 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.17818899 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.17535685 |
| 116 | MP0002081_perinatal_lethality | 0.16760717 |
| 117 | MP0000579_abnormal_nail_morphology | 0.16759632 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.15951333 |
| 119 | MP0004043_abnormal_pH_regulation | 0.15833272 |
| 120 | MP0004272_abnormal_basement_membrane | 0.15350073 |
| 121 | MP0005166_decreased_susceptibility_to | 0.15156626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Type 1 muscle fiber predominance (HP:0003803) | 8.42327917 |
| 2 | Distal arthrogryposis (HP:0005684) | 7.41265824 |
| 3 | Myopathic facies (HP:0002058) | 6.50093976 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.46143503 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.75851849 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.61508728 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.59539908 |
| 8 | Round ear (HP:0100830) | 5.58784244 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.33999917 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.07748399 |
| 11 | EMG: myopathic abnormalities (HP:0003458) | 4.91583114 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.84622739 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 4.66409774 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 4.55142637 |
| 15 | Neck muscle weakness (HP:0000467) | 4.39687653 |
| 16 | Deformed tarsal bones (HP:0008119) | 4.36847165 |
| 17 | Difficulty running (HP:0009046) | 4.33127385 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.25904413 |
| 19 | Fetal akinesia sequence (HP:0001989) | 4.14949183 |
| 20 | Absent phalangeal crease (HP:0006109) | 4.13941710 |
| 21 | Malignant hyperthermia (HP:0002047) | 3.93927739 |
| 22 | Increased connective tissue (HP:0009025) | 3.66349940 |
| 23 | Frequent falls (HP:0002359) | 3.65886160 |
| 24 | Subaortic stenosis (HP:0001682) | 3.54976282 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.54976282 |
| 26 | Muscle stiffness (HP:0003552) | 3.54732577 |
| 27 | Myoglobinuria (HP:0002913) | 3.53480145 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.47177512 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.45864923 |
| 30 | Abnormal finger flexion creases (HP:0006143) | 3.45132323 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.42588999 |
| 32 | Weak cry (HP:0001612) | 3.37445224 |
| 33 | Sudden death (HP:0001699) | 3.30344593 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.28074354 |
| 35 | Bulbar palsy (HP:0001283) | 3.25574945 |
| 36 | Abnormality of the neuromuscular junction (HP:0003398) | 3.23697577 |
| 37 | Fatigable weakness (HP:0003473) | 3.23697577 |
| 38 | Difficulty climbing stairs (HP:0003551) | 3.21072410 |
| 39 | Myotonia (HP:0002486) | 3.16634501 |
| 40 | Slender build (HP:0001533) | 3.11781012 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.07586147 |
| 42 | Generalized muscle weakness (HP:0003324) | 3.05175834 |
| 43 | Gowers sign (HP:0003391) | 3.01855242 |
| 44 | Rhabdomyolysis (HP:0003201) | 3.00107773 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.96570886 |
| 46 | Popliteal pterygium (HP:0009756) | 2.94400822 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.88970678 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.85414706 |
| 49 | Abnormality of the calcaneus (HP:0008364) | 2.78876410 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.76010787 |
| 51 | Scapular winging (HP:0003691) | 2.73441243 |
| 52 | Facial diplegia (HP:0001349) | 2.73190819 |
| 53 | Muscle fiber atrophy (HP:0100295) | 2.71584838 |
| 54 | Spinal rigidity (HP:0003306) | 2.64249922 |
| 55 | Shoulder girdle muscle weakness (HP:0003547) | 2.62186102 |
| 56 | Pelvic girdle muscle weakness (HP:0003749) | 2.61076587 |
| 57 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.52770105 |
| 58 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.52770105 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.49432385 |
| 60 | Abnormality of placental membranes (HP:0011409) | 2.49432385 |
| 61 | Aplasia of the musculature (HP:0100854) | 2.40954826 |
| 62 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.38059999 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.32517553 |
| 64 | Limb-girdle muscle atrophy (HP:0003797) | 2.29144477 |
| 65 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.22788419 |
| 66 | Waddling gait (HP:0002515) | 2.19491469 |
| 67 | Easy fatigability (HP:0003388) | 2.11126438 |
| 68 | Ventricular tachycardia (HP:0004756) | 2.09514259 |
| 69 | Muscular dystrophy (HP:0003560) | 2.03416524 |
| 70 | Ulnar deviation of finger (HP:0009465) | 2.02877085 |
| 71 | Lipoatrophy (HP:0100578) | 2.00700613 |
| 72 | * Muscle fiber inclusion bodies (HP:0100299) | 11.6336115 |
| 73 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.4137781 |
| 74 | * Nemaline bodies (HP:0003798) | 10.0175494 |
| 75 | Dilated cardiomyopathy (HP:0001644) | 1.99000654 |
| 76 | Ragged-red muscle fibers (HP:0003200) | 1.98533193 |
| 77 | Limb-girdle muscle weakness (HP:0003325) | 1.96427846 |
| 78 | Nonprogressive disorder (HP:0003680) | 1.92209233 |
| 79 | Metatarsus adductus (HP:0001840) | 1.91915163 |
| 80 | Exercise intolerance (HP:0003546) | 1.90825932 |
| 81 | * Hip contracture (HP:0003273) | 1.88540826 |
| 82 | Heart block (HP:0012722) | 1.86264416 |
| 83 | Abnormal atrioventricular conduction (HP:0005150) | 1.78223568 |
| 84 | Lower limb amyotrophy (HP:0007210) | 1.76159111 |
| 85 | Hypoplastic ischia (HP:0003175) | 1.72934733 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69399981 |
| 87 | Long clavicles (HP:0000890) | 1.69118710 |
| 88 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.67701277 |
| 89 | Hyperkalemia (HP:0002153) | 1.66921757 |
| 90 | Trismus (HP:0000211) | 1.62606564 |
| 91 | Congenital hip dislocation (HP:0001374) | 1.60949549 |
| 92 | Achilles tendon contracture (HP:0001771) | 1.60820599 |
| 93 | Hypoplastic heart (HP:0001961) | 1.60572692 |
| 94 | Abnormality of the foot musculature (HP:0001436) | 1.60106389 |
| 95 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.58714351 |
| 96 | Akinesia (HP:0002304) | 1.56901590 |
| 97 | Increased muscle lipid content (HP:0009058) | 1.54342278 |
| 98 | Ventricular arrhythmia (HP:0004308) | 1.53961899 |
| 99 | Thin ribs (HP:0000883) | 1.53291005 |
| 100 | Breech presentation (HP:0001623) | 1.52910002 |
| 101 | Adducted thumb (HP:0001181) | 1.51447321 |
| 102 | Bundle branch block (HP:0011710) | 1.50465645 |
| 103 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.50015974 |
| 104 | Tarsal synostosis (HP:0008368) | 1.49417635 |
| 105 | * Proximal amyotrophy (HP:0007126) | 1.47968175 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.47448541 |
| 107 | Paralysis (HP:0003470) | 1.46905530 |
| 108 | Short palpebral fissure (HP:0012745) | 1.33270053 |
| 109 | Generalized amyotrophy (HP:0003700) | 1.32652298 |
| 110 | Steppage gait (HP:0003376) | 1.29350220 |
| 111 | * Progressive muscle weakness (HP:0003323) | 1.25349980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.80962892 |
| 2 | PIK3CG | 4.62394935 |
| 3 | MUSK | 2.85323967 |
| 4 | PHKG1 | 2.50789734 |
| 5 | PHKG2 | 2.50789734 |
| 6 | NME1 | 2.33272665 |
| 7 | MAP2K3 | 2.12663258 |
| 8 | NEK1 | 2.12171699 |
| 9 | TRIB3 | 2.02906381 |
| 10 | OBSCN | 12.9544407 |
| 11 | DMPK | 1.95666685 |
| 12 | MAP3K7 | 1.67267385 |
| 13 | PDK4 | 1.62590521 |
| 14 | PDK3 | 1.62590521 |
| 15 | PINK1 | 1.52385310 |
| 16 | PKN2 | 1.50495781 |
| 17 | MAPK12 | 1.31703983 |
| 18 | AKT2 | 1.01585809 |
| 19 | CCNB1 | 1.01375966 |
| 20 | PDK2 | 0.94905279 |
| 21 | ZAK | 0.92011716 |
| 22 | PIK3CA | 0.91577320 |
| 23 | ILK | 0.86700232 |
| 24 | BCKDK | 0.85209976 |
| 25 | MAP2K4 | 0.82866376 |
| 26 | LIMK1 | 0.82352779 |
| 27 | MAP3K3 | 0.80806505 |
| 28 | MAP2K6 | 0.77825178 |
| 29 | MARK1 | 0.77305157 |
| 30 | TAOK2 | 0.74545150 |
| 31 | STK24 | 0.73417317 |
| 32 | MOS | 0.71835501 |
| 33 | MAPK11 | 0.59687869 |
| 34 | TIE1 | 0.56003730 |
| 35 | MAPKAPK3 | 0.55938742 |
| 36 | MAP3K13 | 0.54340030 |
| 37 | ROCK1 | 0.53121873 |
| 38 | KSR2 | 0.52180132 |
| 39 | CAMK4 | 0.50494120 |
| 40 | CAMK2G | 0.46443652 |
| 41 | MAP3K10 | 0.45386018 |
| 42 | MAP3K11 | 0.45071661 |
| 43 | NEK9 | 0.44474230 |
| 44 | PRKAA1 | 0.44277215 |
| 45 | ARAF | 0.43926477 |
| 46 | RIPK1 | 0.42892557 |
| 47 | CAMK2B | 0.42218031 |
| 48 | TRPM7 | 0.41871239 |
| 49 | MAP3K5 | 0.41339215 |
| 50 | FLT3 | 0.36126321 |
| 51 | ERBB3 | 0.35192628 |
| 52 | PRKAA2 | 0.34525675 |
| 53 | STK38L | 0.33678958 |
| 54 | MYLK | 0.32110286 |
| 55 | CAMK1 | 0.30992294 |
| 56 | TAOK1 | 0.29998039 |
| 57 | SGK3 | 0.29556206 |
| 58 | BRAF | 0.29086365 |
| 59 | TLK1 | 0.28500951 |
| 60 | MAP2K1 | 0.28205900 |
| 61 | MAP3K1 | 0.27764494 |
| 62 | EPHB1 | 0.27368935 |
| 63 | DAPK3 | 0.27314008 |
| 64 | PRKG1 | 0.27227100 |
| 65 | PTK6 | 0.26819569 |
| 66 | ROCK2 | 0.24654577 |
| 67 | CDK19 | 0.24072664 |
| 68 | CDK8 | 0.23943570 |
| 69 | PKN1 | 0.23175447 |
| 70 | TBK1 | 0.21585434 |
| 71 | RPS6KB1 | 0.21377492 |
| 72 | CAMK2D | 0.21094779 |
| 73 | MAP3K9 | 0.20005026 |
| 74 | PRKACB | 0.19560414 |
| 75 | RPS6KA3 | 0.16977394 |
| 76 | PRPF4B | 0.16947355 |
| 77 | MAPK7 | 0.16634587 |
| 78 | RAF1 | 0.16018494 |
| 79 | PRKD1 | 0.15658088 |
| 80 | CDC42BPA | 0.15276367 |
| 81 | LATS2 | 0.14974212 |
| 82 | LRRK2 | 0.14948906 |
| 83 | MAPK4 | 0.14822227 |
| 84 | PDGFRA | 0.13801054 |
| 85 | NME2 | 0.13206260 |
| 86 | FGFR1 | 0.13166039 |
| 87 | SGK1 | 0.13143201 |
| 88 | INSRR | 0.12995672 |
| 89 | RPS6KL1 | 0.12798805 |
| 90 | RPS6KC1 | 0.12798805 |
| 91 | MARK2 | 0.12423755 |
| 92 | PAK4 | 0.12327011 |
| 93 | TGFBR2 | 0.11594070 |
| 94 | PRKACA | 0.11366003 |
| 95 | ICK | 0.09930849 |
| 96 | STK38 | 0.09560534 |
| 97 | CDK6 | 0.09473202 |
| 98 | PTK2B | 0.09303611 |
| 99 | PAK1 | 0.08388490 |
| 100 | DYRK1B | 0.08091311 |
| 101 | KSR1 | 0.08045562 |
| 102 | RPS6KA6 | 0.08027956 |
| 103 | MAP2K2 | 0.08001007 |
| 104 | SIK1 | 0.07516926 |
| 105 | MAPK10 | 0.07432579 |
| 106 | MTOR | 0.07372143 |
| 107 | CAMK2A | 0.07338058 |
| 108 | MAPK13 | 0.07220213 |
| 109 | EPHB2 | 0.07182309 |
| 110 | STK16 | 0.06931200 |
| 111 | PRKACG | 0.06808473 |
| 112 | MST1R | 0.05914182 |
| 113 | CSNK1D | 0.04833949 |
| 114 | GSK3B | 0.04512586 |
| 115 | SGK2 | 0.04144704 |
| 116 | EEF2K | 0.04134844 |
| 117 | PRKG2 | 0.03875763 |
| 118 | ABL2 | 0.03711094 |
| 119 | PDPK1 | 0.03707549 |
| 120 | PBK | 0.03225035 |
| 121 | MAPK8 | 0.01979203 |
| 122 | PDK1 | 0.01862637 |
| 123 | RPS6KB2 | 0.01601755 |
| 124 | MAPKAPK2 | 0.00615977 |
| 125 | PIM2 | 0.00563759 |
| 126 | PRKDC | 0.00171157 |
| 127 | LATS1 | -0.0280520 |
| 128 | CDK14 | -0.0273730 |
| 129 | MAP3K6 | -0.0237899 |
| 130 | BMX | -0.0235682 |
| 131 | CDK4 | -0.0173974 |
| 132 | RPS6KA1 | -0.0123679 |
| 133 | MAPK9 | -0.0089838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 5.28651558 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.10562764 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.88851824 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.83032126 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.04620295 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.62914956 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.45639829 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.35047125 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.26290404 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.17229045 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12376190 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.04172186 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96678553 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93936247 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89877806 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.81211801 |
| 17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78631544 |
| 18 | Tight junction_Homo sapiens_hsa04530 | 1.74076531 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62762437 |
| 20 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.60708432 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.58646412 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52791044 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41177824 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.38353666 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31147773 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24782049 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24678637 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15394016 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.15062886 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08341871 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06498971 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.05620121 |
| 33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.05586563 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04791854 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02469575 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97848937 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97354873 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.97196751 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97070251 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94665354 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92349208 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91200012 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85754175 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76813290 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70219659 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68804541 |
| 47 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65018457 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62407074 |
| 49 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60625388 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58130217 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57907754 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55040176 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54617125 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.51803462 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51249139 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49124635 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45789359 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45385538 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42590261 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.42344578 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42093609 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 0.41158777 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37707046 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.37683333 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37252792 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.37023940 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36835475 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.35401372 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33950789 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31620498 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30779600 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30710541 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.29649955 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25504102 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24278409 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23501631 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.23054695 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22156871 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.21526348 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.21401281 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20569195 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20423054 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20201712 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20195438 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.20170528 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19841568 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19759931 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18955689 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18530467 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18185213 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17401700 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17065269 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.16478569 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.15984471 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15957273 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.15582652 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.14082421 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.13528095 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.13101480 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13039367 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12808967 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11914420 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11875254 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.11720268 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10245409 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09195944 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09113125 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.09106616 |
| 109 | RNA degradation_Homo sapiens_hsa03018 | 0.09098420 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.08784006 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08337594 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.08239048 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.07555292 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.07013918 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.06796073 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06695468 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05658747 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05382954 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.03997215 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.03571449 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.03536430 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.03428532 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.02739010 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.01582928 |

